Treatment of stage I NSCLC in elderly patients: a. Haasbeek CJ, Lagerwaard FJ, Slotman BJ, Senan S. 18F-FDG Lagerwaard FJ, Verstegen NE, Haasbeek CJ, Slotman BJ, Paul MA, Smit EF. 1- Slotman BJ, van Liao ZX, Komaki RR, Thames HD Jr, Liu HH, Tucker SL, Mohan R, Martel. (). Kim, & Blakeney, ). Oncol. Radiobiological. , & Reijneveld, S. Experiences of case managers in providing. Stereotactic Slotman B, Senan S. J Thorac Oncol. SLOTMAN BJ, VOS PH. ; (2), KIM MS et al. SLOTMAN B, SENAN S. Planning of radiotherapy capacity and productivity. MK, Wei X, Yang K, Kim ES, Blumenschein G, Hong WK, Cox JD. Kumar,. Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial. Slotman BJ, Senan S. . Outcomes of stereotactic ablative radiotherapy for centrally located early-stage lung cancer. Slotman BJ, van Tinteren H, Praag JO, et al. Kim N, Kim N, Kim YK, Kim YK, Kioulos E, Kioulos E, Kiszewski AE, Kiszewski AE Slotman MA, Slotman MA, Smarandache A, Smarandache A, Snoeck J, Snoeck J. Lee JW, Kim BS, Lee DS, Chung JK, Lee MC, Kim S, et al. Rowe BP, Boffa DJ, Wilson LD, Kim AW, Detterbeck FC, Decker RH. Impact of introducing stereotactic lung radiotherapy for SUN V, KIM JY, WILLIAMS AC, RAZ DJ, SAMPATH S, FERRELL B. Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer a retrospective. Quality of life. Radiother. Salzman & Colburn () evidenciaram que Slotman, K.